The Pharmacological Burden of Comorbidities in Acromegaly

Background: Acromegaly is characterized by excess GH and elevated IGF-I often treated by surgery, pharmacotherapy (somatostatin analogs, GH receptor antagonists, dopamine agonists) and/or radiotherapy.(1) Common associated comorbidities include cardiovascular disorders and hypopituitarism, often req...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Fleseriu, Maria, Barkan, Ariel, Schneider, Maria del Pilar, Darhi, Yannis, de Pierrefeu, Amicie, Munoz, Kathryn, Ribeiro-Oliveira, Antonio, Melmed, Shlomo
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Neuroendocrinology and Pituitary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090600/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados